Showing results (121-130 of 219) with videos related to

Sort By:
Pageof 22
Respiratory Care|June 9, 2021
Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System DatabaseHyunwoo Kim, Colin M Pfeiffer, Matthew P Gray, et al.
Chest|August 14, 2021
Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series StudyKatherine Callaway Kim, Mina Tadrous, Sandra L Kane-Gill, et al.
Nephron|August 22, 2023
Challenges in Pharmacovigilance: Variability in the Criteria for Determining Drug-Associated Acute Kidney Injury in Retrospective, Observational StudiesNabihah Amatullah, Britney A Stottlemyer, Isabelle Zerfas, et al.
Congestive Heart Failure (Greenwich, Conn.)|February 3, 2007
Resource use in decompensated heart failure by disease progression categoriesSandra L Kane-Gill, Amy L Seybert, Jessica Lazar, et al.
Critical Care Medicine|October 1, 2009
A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unitJoseph F Dasta, Sandra L Kane-Gill, Michael Pencina, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 27, 2014
AKI in low-risk versus high-risk patients in intensive careFlorentina E Sileanu, Raghavan Murugan, Nicole Lucko, et al.
Currents in Pharmacy Teaching & Learning|December 12, 2018
Evaluation of pharmacist satisfaction with simulation-based learning in SingaporeChai Ling Ong, Sandra L Kane-Gill, Lawrence R Kobulinsky, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 4, 2018
Assessing Adverse Drug Reactions from Psychotropic Medications Reported to the U.S. Food and Drug Administration in Older AdultsMatthew P Gray, Gabrielle Dziuba, Karen Quach, et al.
Intensive Care Medicine|March 20, 2010
Impact of simulation-based learning on medication error rates in critically ill patientsDaniel G Ford, Amy L Seybert, Pamela L Smithburger, et al.
Journal of Critical Care|April 24, 2012
Use of an abnormal laboratory value-drug combination alert to detect drug-induced thrombocytopenia in critically Ill patientsLisa M Harinstein, Sandra L Kane-Gill, Pamela L Smithburger, et al.
Pageof 22